Sumitomo Mitsui DS Asset Management Company Ltd Purchases 2,246 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Sumitomo Mitsui DS Asset Management increased its holdings in Intuitive Surgical by 3.7%, acquiring an additional 2,246 shares, bringing their total to 62,407 shares valued at approximately $33.9 million.
• Major institutional investors have significantly increased their stakes in Intuitive Surgical, with some firms like Chilton Capital Management raising their holdings by as much as 614.3%.
• Analysts have mixed opinions on Intuitive Surgical, with a consensus rating of "Moderate Buy" and varying price targets, the highest being $615.00 from Royal Bank of Canada.

Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,407 shares of the medical equipment provider's stock after buying an additional 2,246 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Intuitive Surgical were worth $33,913,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Brighton Jones LLC raised its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG raised its position in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares in the last quarter. Two Sigma Investments LP increased its holdings in Intuitive Surgical by 10,708.5% in the 4th quarter. Two Sigma Investments LP now owns 68,310 shares of the medical equipment provider's stock worth $35,655,000 after acquiring an additional 67,678 shares in the last quarter. Visionary Wealth Advisors lifted its position in Intuitive Surgical by 4.7% during the fourth quarter. Visionary Wealth Advisors now owns 945 shares of the medical equipment provider's stock worth $493,000 after buying an additional 42 shares in the last quarter. Finally, Vident Advisory LLC increased its position in shares of Intuitive Surgical by 11.2% during the 4th quarter. Vident Advisory LLC now owns 8,972 shares of the medical equipment provider's stock worth $4,684,000 after purchasing an additional 904 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the company's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. Corporate insiders own 0.70% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Royal Bank Of Canada reiterated an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Wells Fargo & Company raised their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Finally, Truist Financial raised their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $6.50 during trading hours on Monday, hitting $445.22. The company had a trading volume of 843,930 shares, compared to its average volume of 2,038,936. The firm has a 50-day moving average of $476.64 and a 200 day moving average of $503.43. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market cap of $159.60 billion, a PE ratio of 62.33, a PEG ratio of 4.60 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the business posted $1.78 EPS. Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.